-
Trump renames AI "super intelligence," rejects international oversight
-
Moldova declares energy, water emergency
-
Trump rejects international regulation of AI
-
French Holocaust denier jailed for eight months
-
How is the EU approaching record fuel prices?
-
Oil prices slide, AI stock buzz fades
-
Sri Lanka's Colombage strikes on debut as England dismissed for 265 in first ODI
-
Trump threatens to 'annihilate' Iran in bombastic UN speech
-
Hurricane Polo strengthens to top category 5 off Mexico
-
Prada's skirts take centre stage as Milan Fashion Week begins
-
11 hurt as teen opens fire outside school in western Turkey
-
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
-
UN chief says 'Big Oil' treats atmosphere as open sewer
-
Brazil's Flavio Bolsonaro turns scandal into poll gains
-
Tunisia says 2026 summer hottest on record
-
Republican senator seeks probe of Trump Jr Russian-funded wedding
-
England's Rashid out of Sri Lanka ODIs with hand injury
-
Memoir by Diana's brother goes on sale after rocking UK monarchy
-
Houthis accuse Saudi Arabia of deadly strikes as thousands flee
-
Newcomers South Korea face holders Italy in Davis Cup finals
-
Stocks climb as oil slides, AI buzz returns
-
Japan's Kojima sounds Marchand warning with Asian Games gold
-
India cricketers win in style as Afghan savours 'special' Games silver
-
England rugby star Pollock signs new Northampton deal
-
La Liga president hits out at Real Madrid refereeing 'conspiracy' claims
-
STARTRADER Expands Its Chinese Equity CFD Range with CXMT and Unitree Robotics
-
MEXC Launches “Real Stocks, Real Friends” with Rewards for Bringing Friends to Wall Street
-
MEXC Expands Opportunity Compass with Stock Trading Handbook to Help Crypto Users Build Investment Knowledge
-
Mbappe continues media push for Ballon d'Or recognition
-
England paceman Wood retires from international cricket
-
Stocks rise on AI buzz, oil prices cool
-
Magnificent Mandhana's 79 helps India to Asian Games cricket gold
-
India narrowly survive huge scare against minnows Japan
-
Marchand 'stressed' about racing Japanese rivals at LA Olympics
-
Missing F-35 fighter parts 'not sensitive', says Australia minister
-
Mobile boat clinics bring healthcare to India's remote islands
-
Cambodia showcases scams crackdown with global conference
-
Former India paceman Zaheer Khan named Chennai coach in IPL
-
Afghan cyclist who disguised herself as man wins Asian Games silver
-
Six-year-old Chinese girl sets world record with Rubik's Cube
-
Typhoon Dujuan leaves four dead in Japan, 45,000 houses without power
-
Swimming prodigy Yu, 13, says 'interviews way harder than racing'
-
G7 leaders condemn Houthi strikes on Saudi Arabia
-
Star coaches make their bows as Nations League returns
-
Google data centre sparks protests in Austria
-
Rams bounce back as Giants reel from Dart injury
-
Shin Ohashi: Junk food-loving teen and Japan's next big swimming hope
-
In Bangladesh, Pakistan's Jinnah photo stirs anger
-
Stocks rise on AI buzz, drop in oil prices
-
Two New Zealand naval ships transit Taiwan Strait
Global Covid cases up 80% as new subvariant rises
The number of new Covid-19 cases reported worldwide rose by 80 percent in the last month, the World Health Organization said on Friday, days after designating a new "variant of interest".
The WHO declared in May that Covid is no longer a global health emergency, but has warned that the virus will continue to circulate and mutate, causing occasional spikes in infections, hospitalisations and deaths.
In its weekly update, the UN agency said that nations reported nearly 1.5 million new cases from July 10 to August 6, an 80 percent increase compared to the previous 28 days.
However the number of deaths fell by 57 percent to 2,500.
The WHO warned that the reported number of cases and deaths do not reflect the true numbers, in part because countries carry out far less testing and monitoring than during earlier stages of the pandemic.
Many of the new cases came in the Western Pacific region, which saw infections jump by 137 percent, the WHO said.
Several countries in the Northern Hemisphere, including the United States, United Kingdom, France and Japan have seen a summer uptick in cases in recent weeks.
Experts have suggested that summer gatherings and travel, declining immunity and a new subvariant may have all played a role in the increase.
On Wednesday, the WHO designated the Omicron subvariant EG.5 as a "variant of interest" following a steady rise in its prevalence.
More than 17 percent of all reported cases were EG.5 in mid-July, up from 7.6 percent a month before, according to the WHO.
- Subvariant poses 'low' risk -
EG.5, which has been unofficially nicknamed "Eris" online, is considered to be a descendant of the XBB lineage of the virus.
It seems to be more transmissible than other circulating variants, likely due to a mutation in its spike protein, and the WHO said it has shown an ability to evade immunity.
But there is no sign that EG.5 causes more severe Covid symptoms and it poses a "low" risk to global public health, the WHO said, comparing its threat to other recent Omicron subvariants.
Nonetheless, WHO chief Tedros Adhanom Ghebreyesus warned that "the risk remains of a more dangerous variant emerging that could cause a sudden increase in cases and deaths".
France's Health Minister Aurelien Rousseau called for vigilance, while emphasising that Covid numbers remain at low levels.
"We will have to live with the resurgence of this virus for several seasons to come," he said in a statement sent to AFP.
Antoine Flahault, director of the Institute of Global Health at the University of Geneva, told AFP that the true Covid situation remained unclear "just about everywhere in the world".
"Health authorities urgently need to reinstate a reliable Covid health monitoring system," he said, calling for wastewater to be analysed to detect virus trends.
While the impact of Covid has been greatly diminished due to high levels immunity from either vaccination or prior infection, the virus still poses a threat -- including long Covid, for which symptoms can last for months or years.
The WHO has urged countries to ramp up vaccination efforts.
Pharmaceutical firms Pfizer/BioNTech, Moderna and Novavax are all working on updating their Covid vaccines to target XBB subvariants.
J.Fankhauser--BTB